Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-3155
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis ; volume:8 ; number:1 ; day:24 ; month:9 ; year:2010 ; pages:1-18 ; date:12.2010
Journal of nanobiotechnology ; 8, Heft 1 (24.9.2010), 1-18, 12.2010
- Urheber
-
Vij, Neeraj
- Beteiligte Personen und Organisationen
-
Min, Taehong
Marasigan, Rhul
Belcher, Christopher N.
Mazur, Steven
Ding, Hong
Yong, Ken-Tye
Roy, Indrajit
SpringerLink (Online service)
- DOI
-
10.1186/1477-3155-8-22
- URN
-
urn:nbn:de:1111-2016073038482
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vij, Neeraj
- Min, Taehong
- Marasigan, Rhul
- Belcher, Christopher N.
- Mazur, Steven
- Ding, Hong
- Yong, Ken-Tye
- Roy, Indrajit
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery
Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers
Preparation and evaluation of amphipathic lipopeptide‐loaded PLGA microspheres as sustained‐release system for AIDS prevention
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery
Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers
Preparation and evaluation of amphipathic lipopeptide‐loaded PLGA microspheres as sustained‐release system for AIDS prevention
Optimization and in Vitro Evaluation of Injectable Sustained-Release of Levothyroxine Using PLGA-PEG-PLGA
Passively Targeted Curcumin‐Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
Attenuation of skin injury by a MARCO targeting PLGA nanoparticle
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
PLGA-based micro- and nanoparticle development for chemically modified messenger RNA delivery
Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers